Belgium· BE-AMP-SAM185473-00

Avaxim

A hepatitis a, inaktiviert, ganzes virus product containing hepatitis a virus (inactivated), registered in Belgium by Sanofi Winthrop Industrie. The same ATC class is registered in 11 of our 19 countries.

ATC J07BC02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAvaximATCJ07BC02REGISTER NO.BE-AMP-SAM185473-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Hepatitis a, inaktiviert, ganzes virus is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BC02 (hepatitis a, inaktiviert, ganzes virus), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Hepatitis a, inaktiviert, ganzes virus · ATC J07BC02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Hepatitis A Virus (inactivated)
Manufacturer
Sanofi Winthrop Industrie
Country
Belgium (BE)
ATC code
J07BC02
ATC class
Hepatitis A, inaktiviert, ganzes Virus
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    1321058

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Hepatitis a, inaktiviert, ganzes virus in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hepatitis a, inaktiviert, ganzes virus products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Greece · Havrix Παιδιατρικό
  • Portugal · Havrix Júnior

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/448611f6-1bad-450a-be7e-5676e9631b29
GET /v1/drugs/448611f6-1bad-450a-be7e-5676e9631b29?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Avaxim",
  "name_fr": "Avaxim",
  "name_nl": "Avaxim",
  "amp_code": "SAM185473-00",
  "strengths": [
    "160.0000",
    "160.0000",
    "12.5000"
  ],
  "pack_count": 9,
  "substances": [
    "Hepatitis A Virus (inactivated)",
    "Formaldehyde",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Hepatitis A, Inactivated, Whole Virus",
  "authorisation_numbers": [
    "BE185473"
  ]
}

See everything about hepatitis a, inaktiviert, ganzes virus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.